Annoek B.
- Country
- The Netherlands
- Department
- Hematology
Research Overview
- Evaluation of Belumosudil and Prednisone Versus Placebo and Prednisone in Patients Aged 12 and Older with Newly Diagnosed Chronic Graft-Versus-Host Disease
- Phase 3 Randomized Open-Label Study of Axatilimab Versus Best Available Therapy in Chronic Graft-Versus-Host Disease Post Two Systemic Therapy Lines
Data & Insights
Has run more than one trial at 50 of 125 partner sites.
Specializations
Transplant Medicine
The investigator specializes in the treatment of chronic graft versus host disease, a significant complication following stem cell transplantation. Their research encompasses innovative therapeutic approaches combining established and novel treatments.
- Post-transplant complications
- Immunological responses
- Chronic GVHD management
Their focus includes exploring therapeutic solutions for transplant recipients developing chronic conditions.
Immunotherapy
The investigator's work centers on developing combination treatment strategies involving novel agents and conventional therapeutics. Their expertise extends to immunomodulatory approaches in transplant medicine.
- Immune system regulation
- Therapeutic combinations
- Novel drug development
The research involves evaluating new therapeutic options for immune-mediated conditions.
Clinical Innovation
The investigator pursues advancement in treatment protocols for chronic conditions following transplantation. Their work emphasizes the development of oral therapeutic options for patients with post-transplant complications.
- Treatment optimization
- Drug efficacy assessment
- Patient outcomes research
Their research aims to improve survival outcomes in transplant recipients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.